BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21528670)

  • 21. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
    Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
    Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.
    Deng B; Sun Z; Jason W; Yang P
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S701-8. PubMed ID: 23904007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
    Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
    Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
    Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
    Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Ishikawa S; Kontani K; Yokomise H; Ueno M
    J Clin Oncol; 2005 Dec; 23(34):8765-73. PubMed ID: 16314637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and clinical significance of miR-139-5p in non-small cell lung cancer.
    Yong-Hao Y; Xian-Guo W; Ming X; Jin-Ping Z
    J Int Med Res; 2019 Feb; 47(2):867-874. PubMed ID: 30614351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain.
    Grinberg-Rashi H; Ofek E; Perelman M; Skarda J; Yaron P; Hajdúch M; Jacob-Hirsch J; Amariglio N; Krupsky M; Simansky DA; Ram Z; Pfeffer R; Galernter I; Steinberg DM; Ben-Dov I; Rechavi G; Izraeli S
    Clin Cancer Res; 2009 Mar; 15(5):1755-61. PubMed ID: 19190132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.
    Zhang YK; Zhu WY; He JY; Chen DD; Huang YY; Le HB; Liu XG
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1641-50. PubMed ID: 22618509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.
    Takada M; Tada M; Tamoto E; Kawakami A; Murakawa K; Shindoh G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Fujiwara Y; Shirata K; Nishimura N; Miyamoto M; Okushiba S; Kondo S; Hamada J; Katoh H; Yoshiki T; Moriuchi T
    J Surg Res; 2004 Nov; 122(1):61-9. PubMed ID: 15522316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and identification of distant metastasis-related differentially expressed genes in human squamous cell lung carcinoma.
    Wang N; Zhou F; Xiong H; Du S; Ma J; Okai I; Wang J; Suo J; Hao L; Song Y; Hu J; Shao S
    Anat Rec (Hoboken); 2012 May; 295(5):748-57. PubMed ID: 22419659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of miR-96, a potential biomarker of NSCLC, through bioinformatic analysis.
    Cai T; Long J; Wang H; Liu W; Zhang Y
    Oncol Rep; 2017 Aug; 38(2):1213-1223. PubMed ID: 28656287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.
    Zhan P; Shen XK; Qian Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
    Med Oncol; 2012 Jun; 29(2):648-55. PubMed ID: 21519871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of Nemo‑like kinase promotes metastasis in non‑small‑cell lung cancer.
    Shi C; Xu L; Tang Z; Zhang W; Wei Y; Ni J; Zhang S; Feng J
    Oncol Rep; 2019 Sep; 42(3):1090-1100. PubMed ID: 31322229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
    Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
    Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
    Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
    Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.